| [1] |
曹丹庆. 全身CT诊断学[M]. 北京: 人民军医出版社, 1996.
|
| [2] |
Cattell R, Ying J, Lei L, et al. Preoperative prediction of lymph node metastasis using deep learning-based features[J]. Vis Comput Ind Biomed Art, 2022, 5(1): 8. DOI: 10.1186/s42492-022-00104-5.
|
| [3] |
Kemppainen J, Hynninen J, Virtanen J, et al. PET/CT for evaluation of ovarian cancer[J]. Semin Nucl Med, 2019, 49(6): 484-492. DOI: 10.1053/j.semnuclmed.2019.06.010.
|
| [4] |
Devine C, Viswanathan C, Faria S, et al. Imaging and staging of cervical cancer[J]. Semin Ultrasound CT MR, 2019, 40(4): 280-286. DOI: 10.1053/j.sult.2019.03.001.
|
| [5] |
Mansoori B, Khatri G, Rivera-Colón G, et al. Multimodality imaging of uterine cervical malignancies[J]. AJR Am J Roentgenol, 2020, 215(2): 292-304. DOI: 10.2214/AJR.19.21941.
|
| [6] |
Papadia A, Gasparri ML, Genoud S, et al. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer[J]. J Cancer Res Clin Oncol, 2017, 143(11): 2275-2281. DOI: 10.1007/s00432-017-2467-6.
|
| [7] |
Goense L, Meziani J, van Rossum PSN, et al. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis[J]. Nucl Med Commun, 2018, 39(7): 645-651. DOI: 10.1097/MNM.0000000000000847.
|
| [8] |
Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation[J]. J Nucl Med, 2002, 43(5): 658-663.
|
| [9] |
McBride OM, Joshi NV, Robson JM, et al. Positron emission tomography and magnetic resonance imaging of cellular inflammation in patients with abdominal aortic aneurysms[J]. Eur J Vasc Endovasc Surg, 2016, 51(4): 518-526. DOI: 10.1016/j.ejvs.2015.12.018.
|
| [10] |
Zhang J, Dong MJ, Liu KF, et al. (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography in patients with Kikuchi-Fujimoto disease: a nine-case series in China[J]. Int J Clin Exp Med, 2015, 8(11): 21034-21043.
|
| [11] |
Schönau V, Vogel K, Englbrecht M, et al. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study[J]. Ann Rheum Dis, 2018, 77(1): 70-77. DOI: 10.1136/annrheumdis-2017-211687.
|
| [12] |
Motegi SI, Fujiwara C, Sekiguchi A, et al. Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis[J]. J Dermatol, 2019, 46(3): 213-218. DOI: 10.1111/1346-8138.14758.
|
| [13] |
Shvero A, Hubosky SG. Management of upper tract urothelial carcinoma[J]. Curr Oncol Rep, 2022, 24(5): 611-619. DOI: 10.1007/s11912-021-01179-8.
|
| [14] |
Grahn A, Coleman JA, Eriksson Y, et al. Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?[J]. World J Urol, 2023, 41(12): 3405-3411. DOI: 10.1007/s00345-023-04597-4.
|
| [15] |
Fujii Y, Sato Y, Suzuki H, et al. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma[J]. Cancer Cell, 2021, 39(6): 793-809.e8. DOI: 10.1016/j.ccell.2021.05.008.
|
| [16] |
Guo RQ, Xiong GY, Yang KW, et al. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: a prospective, single-center study[J]. Urol Oncol, 2018, 36(7): 342.e15-342.e23. DOI: 10.1016/j.urolonc.2018.04.001.
|
| [17] |
Xu C, Yuan C, Zhang C, et al. The evolution of clinicopathological diagnostic features of upper tract urothelial carcinoma in China: a summary of 2561 cases in the last 20 years[J]. Front Oncol, 2022, 12: 769252. DOI: 10.3389/fonc.2022.769252.
|
| [18] |
Rouprêt M, Seisen T, Birtle AJ, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update[J]. Eur Urol, 2023, 84(1): 49-64. DOI: 10.1016/j.eururo.2023.03.013.
|
| [19] |
Sydén F, Baard J, Bultitude M, et al. Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?[J]. World J Urol, 2023, 41(12): 3395-3403. DOI: 10.1007/s00345-023-04530-9.
|